SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-044180
Filing Date
2011-08-05
Accepted
2011-08-05 13:47:53
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v229354_10q.htm 10-Q 1511171
2 v229354_ex31-1.htm EX-31.1 14460
3 v229354_ex31-2.htm EX-31.2 14070
4 v229354_ex32-1.htm EX-32.1 6645
5 v229354_ex32-2.htm EX-32.2 6311
  Complete submission text file 0001144204-11-044180.txt   5405132

Data Files

Seq Description Document Type Size
6 scmp-20110630.xml EX-101.INS 909657
7 scmp-20110630.xsd EX-101.SCH 15287
8 scmp-20110630_cal.xml EX-101.CAL 46600
9 scmp-20110630_def.xml EX-101.DEF 115014
10 scmp-20110630_lab.xml EX-101.LAB 111382
11 scmp-20110630_pre.xml EX-101.PRE 125083
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 111013561
SIC: 2834 Pharmaceutical Preparations